Peijia Medical Executive and Leadership Team

Michael Zhang, the Chairman & Chief Executive Officer at Peijia Medical, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the expansion into global structural heart and neurovascular markets, the Chairman & Chief Executive Officer ensures alignment between clinical research goals and commercial objectives. This leadership role involves managing high-level relationships with international healthcare partners and investors to sustain growth. By prioritizing the development of aortic, mitral, and tricuspid valve technologies, Michael Zhang directly influences the trajectory of medical innovation within the company. The Chairman & Chief Executive Officer maintains a focus on scaling operations to meet the rising demand for advanced cardiovascular interventions. Through rigorous oversight of corporate governance and strategic resource allocation, Zhang secures the competitive position of the firm in the complex landscape of high-end medical device manufacturing.

Leo Tsai, the Chief Financial Officer at Peijia Medical, manages the fiscal health and capital structure of the enterprise. Overseeing financial planning, reporting, and risk management, the Chief Financial Officer ensures the availability of resources for research and development in structural heart disease solutions. This leadership role involves coordinating with the Board to optimize capital allocation across diverse neurovascular intervention product lines. By implementing robust financial controls, Leo Tsai supports the sustainable growth of the company in international markets. The Chief Financial Officer drives transparency in reporting and maintains strong relationships with institutional stakeholders to facilitate ongoing investment. Through the analysis of market trends and operational costs, Tsai provides the necessary data to guide strategic decision-making. Ultimately, the Chief Financial Officer strengthens the balance sheet to support the long-term mission of delivering innovative medical products to hospitals worldwide.

Karl Pan, the Chief Operating Officer at Peijia Medical, manages the internal scaling and manufacturing efficiency of the company. Overseeing the supply chain and production processes, the Chief Operating Officer ensures the consistent delivery of high-end medical devices to hospitals and healthcare providers. This leadership role involves optimizing operational workflows to maintain quality standards across all structural heart and neurovascular product lines. By streamlining logistics and manufacturing operations, Karl Pan supports the company's ability to meet increasing market demand. The Chief Operating Officer coordinates with cross-functional teams to ensure that production capacity aligns with strategic growth targets. Through the implementation of lean manufacturing principles, Pan enhances operational productivity and reduces lead times for critical medical interventions. Ultimately, the Chief Operating Officer maintains the operational infrastructure required to sustain the company's commitment to providing safe and effective medical solutions.

JianFong Tan, the Chief Technology Officer at Peijia Medical, leads the research and development initiatives for structural heart and neurovascular intervention products. Overseeing the engineering teams, the Chief Technology Officer drives the creation of next-generation aortic, mitral, and tricuspid valve technologies. This leadership role involves bridging the gap between clinical requirements and technical execution to ensure product safety and efficacy. By fostering a culture of continuous innovation, JianFong Tan accelerates the development cycle of surgical accessories and specialized medical devices. The Chief Technology Officer collaborates with clinical experts to refine product designs that address complex cardiovascular challenges. Through the management of intellectual property and technical roadmaps, Tan ensures the company remains at the forefront of medical device manufacturing. Ultimately, the Chief Technology Officer delivers the technical breakthroughs necessary to improve patient quality of life across global healthcare systems.